Abstract:As a complex disease, the development and progression of hepatocellular carcinoma (HCC) involves the interactions of multiple proteins, genes and miRNAs in various biological pathways, and it has been extensively studied with different high-throughput techniques. However, efforts to integrate multiple data sources at different levels, especially with regard to biological pathways and interaction networks, are still negligible in the HCC research field. We have built a database of the HCC network (HCCNet) by integrating interactions of multiple proteins, genes and miRNAs in biological pathways, and manually collecting all of the HCC-related genes and miRNAs from the literature in combination with a bioinformatic analysis of the collected HCC expression data (Supplementary information, Data S1). Currently, there are 37 811 experimentally confirmed protein-protein interactions (PPIs), 9 148 experimentally confirmed transcriptional regulatory interactions (TRIs), 114 miRNA-target gene interactions, 2 234 high-confidence HCC-related genes and 160 HCC-related miRNAs available in the database. The database also provides an online graphic analysis tool to view the interactions among HCC-related proteins, genes and miRNAs. HCCNet is a helpful platform to explore the molecular mechanisms that underlie human HCC. The database can be accessed at http://www.megabionet.org/hcc. We collected data from experimentally confirmed PPIs from the Human Protein Reference Database (HPRD) 1. PPIs that were accompanied by at least one literature citation (PubMed ID) and confirmed by at least one experimental method were thought to be of high quality. Examples of experimentally confirmed TRIs were collected from either published transcriptional regulation studies or the TRANSFAC 7.0 public database. TRIs that were supported by at least one independent wet experimental study were thought to be of high quality. These high-quality PPIs and TRIs were selected for further biological network construction in our HCCNet system. Moreover, we used “miRNA” and “hepatocellular carcinoma” as key words to search for literature in the PubMed database, and added miRNAs that were reported to be differentially expressed in human HCC, including their target genes from these published papers to our system. Even though some of the collected target genes for miRNAs were merely predicted and not proven, we believed that the results were useful, as they were provided by authors and subjected to the peer review process. High-confidence HCC-related genes were obtained through microarray analysis and literature mining. We first used “hepatocellular carcinoma” as key words to search the GEO database for published HCC microarray data. We then selected those microarray data generated from human HCC patients. After microarray analysis, we selected those DEGs that were up- or down-regulated in more than half of the samples in at least one independent microarray study, and that were supported by at least two independent human HCC microarray studies as high-confidence HCC-related genes (Supplementary information, Data S1). We used “gene” and “hepatocellular carcinoma” as key words to search for published papers from the PubMed database. We then selected the HCC-related genes that were supported by at least two published manuscripts and labeled these as high-confidence HCC-related genes. With the criteria mentioned above, 2 234 high-confidence HCC-related genes were inputted into the HCCNet. miRNAs are not as well studied as genes are in the field of HCC. To include as much data and information related to miRNAs as possible, we did not select high-confidence HCC-related miRNA as stringently as we did for HCC-related genes. Instead, HCC-related miRNAs that were supported by at least one literature source were selected as high-confidence HCC-related miRNAs. A total of 160 miRNAs fit into this category and are regarded as high-confidence HCC-related miRNAs. Currently, there are two databases, OncoDB.HCC 2 and EHCO 3, which have collected thousands of genes that have been shown to be differentially expressed in some microarray studies related to liver cancer. The EHCO has also done some network analysis among the hundreds of genes based on predicted PPI data 3. However, efforts to integrate multiple data sources at different levels, especially with regard to biological pathways and interaction networks, are still exiguous in the field of HCC. Both OncoDB.HCC and EHCO are a collection of single HCC genes and do not address more complex interactions. As an attempt to integrate multiple data sources at different levels, especially with regard to biological pathways and interaction networks, we built the HCCNet database by integrating experimentally confirmed PPIs, TRIs and miRNA-target gene interactions into a biological network (Supplementary information, Data S1). Gene expression patterns in HCC, KEGG pathways, Gene Ontology and subcellular localization were used to annotate nodes on the network. We also selected high-confidence HCC-related genes and miRNAs, and mapped them to the biological network (Supplementary information, Data S1). We made a comparison of the HCC-related genes in HCCNet with the genes in other HCC databases (OncoDB.HCC and EHCO). The results show that about half of the genes in our database are also collected in the other two databases (Supplementary information, Figure S1), indicating a greater number of HCC genes in the HCCNet. OncoDB.HCC did not include miRNAs and EHCO only offered a downloadable file that contained about 70 miRNAs in HCC. Compared to these sources, HCCNet offers a higher quantity and quality of HCC-related miRNAs. Moreover, HCCNet is not a simple collection of HCC-related genes and miRNAs, as it organizes and displays HCC factors in an interactive way. An online graphic tool was developed to display and analyze the HCC-related biological network in HCCNet. As a result, HCCNet is a platform to explore the molecular mechanism that underlies the development and progression of HCC. In the current release version, there are 37 811 PPIs, 9 148 TRIs, 114 miRNA-target gene interactions, 2 234 high confident HCC-related genes and 160 HCC-related miRNAs available in the HCCNet database. The development and progression of HCC cannot be determined by a single factor or a simple collection of factors, but rather by interactions of multiple proteins, genes and miRNAs in various biological pathways. Previous studies on protein–protein interaction networks in liver cancer have found many interactions among proliferation and apoptosis-related proteins and differential glycoproteins; thus, it is proposed that instead of analyzing a single or a few proteins, a “molecule groups” concept should be introduced into the diagnosis and metastasis prediction of HCC 4. Hence, instead of analyzing a single or a small subset of proteins, the “molecule groups” concept has been introduced into our HCCNet system. In this way, a HCC-related gene/miRNA that interacts with others could be used as a network entry point to draw a HCC-related biological network and discover potential HCC-related functional modules. HCCNet offers a variety of ways (Figure 1) for users to gain network entry. The first and most important way is to search for high-confidence HCC-related genes in HCCNet by symbol, alias or full name of the gene of interest. For users who do not have a particular gene in mind, alternative approaches are offered in HCCNet: one could select high-confidence HCC-related genes by pathway and subcellular localization on the query page; one could also select high-confidence HCC-related genes by chromosome on the chromosome viewer page; we have also provided a high-confidence HCC-related gene list sorted alphabetically by gene symbol; and lastly, one could search for HCC-related miRNAs by symbol or select one in the HCC-related miRNA list. The target genes of a miRNA are provided in both the list and the search result. If the high-confidence HCC-related gene/miRNA is a network entry, one can find the hyperlink “show network” on the page. This link leads the user to the display center, in which they can view the displayed biological network expanded from the network entry node with our graphic tool. All the annotations, such as expression patterns in HCC, biological pathways, subcellular localizations, functions and gene ontology annotations, can be found in detailed information pages of the gene entry. Furthermore, if the queried gene is expressed in normal liver, related hyperlinks can be used to view the detailed transcriptomics and proteomics information about this gene in the ATP-HL system. HCCNet not only lists the high-confidence HCC-related genes that are mapped to the KEGG pathways, but also maps these genes to the pathway in a graphic way (Supplementary information, Figure S2). In this way, it will be easier for users to study how these genes co-operate or how this pathway is activated in HCC. With HCCNet, when the user studies the molecular network environments of a high-confidence HCC-related gene or miRNA, and checks if any kind of functional module exists when the gene or miRNA is activated in HCC, one should gain network entry by searching or selecting a gene or miRNA from the gene or miRNA list first. Then one can view the biological network expanded from the entry node with our graphic tool. Alternatively, one can expand the network from a group of entries selected by biological pathway and subcellular localization. If the user wants to expand the biological network in this way, they should select a pathway and a subcellular localization on the query page, and then choose the button “view network”. With our graphic tool (Supplementary information, Figure S3), the network can be expanded from the node of network entry or nodes of entries by edges. With the optimization of algorithms, the components of the displayed network can be expanded to 600 nodes or until no new node can be added by the edges. In this way, users can analyze and visualize the HCC-related genes and miRNAs in a global view. In addition, users can filter nodes by pathway, subcellular localization, function, degree or other options that are listed to the right of the display. Furthermore, we also provide a function that users can expand the network from the selected limbic node. One can check the selection function on the right menu. In conclusion, HCCNet is a useful platform when exploring the molecular mechanisms that underlie HCC (Supplementary information, Data S1). In the current release version of HCCNet, the interactions of miRNA-target genes are not as reliable as PPIs and TRIs (Supplementary information, Data S1). However, the selection criterion will become stricter with the accumulation of more related experimentally validated data. The collection of HCC-related genes and miRNAs will continue in the future. To better improve the system, HCCNet will keep pace with the novel discoveries and progress in the liver cancer research field. One of our goals is to identify those signal transduction pathways that have significant changes and explore the relationships between those pathways during the pathological processes. At the same time, we will also catalog the downstream genes for each altered signaling pathway in live cancer and ultimately fulfill the goal of identifying new potentially relevant liver cancer genes and new mechanisms. We are very thankful to Dr Dušan M Jeftinija (Department of Neurosience & Anatomy, University of Louisville, Kentucky, USA) for his help during the manuscript preparation. This work was supported by grants from the State Key Program of Basic Research of China (2007CB108800, 2009CB918400, 2010CB912102), the Hi-Tech Research and Development Program of China (2006AA02Z313), National Natural Science Foundation of China (30870575) and Science and Technology Commission of Shanghai Municipality (06DZ22923). (Supplementary information is linked to the online version of the paper on the Cell Research website.)

Abstract:Now it is widely acknowledged that genetically caused diseases or disorders (e.g., cancer, AIDS, and obesity) stem from the dysfunction of molecular biological systems, not only their isolated components (e.g., genes, proteins, and metabolites). With advances in high-throughput measurement techniques, large-scale biological data have been and will continuously be produced. Such data contain insightful information for understanding the mechanism of molecular biological systems and have proved useful in diagnosis, treatment, and drug design for genetically caused diseases or disorders. In this special issue, we reported the recent progress in computational approaches that have been developed for analyzing complex networks constructed from high-throughput data and their applications to human diseases. High-throughput experimental technologies, along with computational predictions, have produced a large amount of protein-protein interaction (PPI) data and thus PPI networks, which makes it possible to understand the role of proteins or genes at the network level. Protein complexes are molecular aggregations of proteins assembled via multiple PPIs. Most proteins are functional only when they are assembled into a protein complex and interact with other proteins in this complex. Therefore, identification of protein complexes from PPI networks has become a key problem for understanding cellular life in postgenomic era. In the paper “ABC and IFC: modules detection method for PPI network,” X. Lei et al. proposed a novel clustering model which combined the optimization mechanism of artificial bee colony (ABC) with the fuzzy membership matrix to detect protein complexes from PPI networks. The experimental results on MIPS dataset showed that their proposed ABC-IFC method not only got improved in terms of several commonly used evaluation criteria such as precision, recall, and P value but also obtained a better clustering result. Due to the limitation of experiments, there are a substantial number of false positives of the PPIs which can compromise the utility of PPI networks for protein complex detection. To address this issue, a number of data integration and affinity scoring schemes have been devised to get a weighted PPI network. In the paper “A novel algorithm for detecting protein complexes with the breadth first search,” X. Tang et al. proposed a novel protein complex mining algorithm ClusterBFS (cluster with breadth first search) to detect the protein complexes from the weighted PPI network. The experimental results showed that ClusterBFS performed significantly better than the other computational approaches in terms of the identification of protein complexes. Most existing computational methods were applied on static PPI networks to identify the protein complex. However, proteins and their interactions are dynamic in reality. Therefore, identifying dynamic protein complexes is more meaningful and challenging. In their paper “Identifying dynamic protein complexes based on gene expression profiles and PPI networks,” M. Li et al. integrated static PPI data and dynamic gene expression profiles to construct dynamic PPI networks and further proposed a novel algorithm, named DPC, to identify dynamic protein complexes. Their proposed algorithm DPC was applied on the data of Saccharomyces cerevisiae and the experimental results showed that DPC outperformed CMC, MCL, SPICi, HC-PIN, COACH, and Core-Attachment based on the validation of matching with known complexes and hF-measures. In their paper “msiDBN: a method of identifying critical proteins in dynamic PPI networks,” Y. Zhang et al. presented a comprehensive way of modeling the dynamic PPIs and further proposed a novel method, named msiDBN, for modeling a common representation of multiple PPI networks. Experiments were implemented on data of yeast cell cycles. The results of comparison showed that msiDBN had better reconstruction rate and identified more proteins of critical value to yeast cell cycle process. In F. Liu et al.'s paper “Mining seasonal marine microbial pattern with greedy heuristic clustering and symmetrical nonnegative matrix factorization,” they developed a novel method called HCsNMF to detect the marine microbial association patterns. The results showed that the four seasonal marine microbial association networks had characters of complex networks. Cancer is characterized by uncontrolled cell growth as a consequence of activating protooncogenes and/or inactivating tumor suppressor genes. Searching for consistently up- or downregulated genes, proteins, or clusters of them has been the mainstream in identifying potential biomarkers for early cancer diagnosis. However, tumorigenesis as well as cancer progression is a complex and dynamic process. The recent study showed that the characteristics of biomolecular networks for disease cells could be significantly different from those for normal cells. Based on this observation, B. Ling et al. tested the hypothesis that correlations for gene expressions could serve as valid indicators of early cancer development in their paper “Gene expression correlation for cancer diagnosis: a pilot study.” Their results showed that strong correlations were observed between genes that are even not on the same pathways during the progression of different cancers, implicating that the correlations for cancer network gene expressions could serve as a supplement to current clinical biomarkers. Cancer starts from normal cells, acquires mutations, and evolves to be malignant cancer cells that are metastatic and/or resistant to therapy. Therefore, identifying driver mutation is important in understanding disease mechanism and future application of custom tailored therapeutic decision. In their paper “Pathway-driven discovery of rare mutational impact on cancer,” T. Ahn and T. Park suggested a new approach for discovering rare mutations that have real impact in the context of pathway, which could sensitively capture mutations that change pathway level of mRNA expression. Finding effective anticancer therapies is a major goal of biomedical research. Recently, synthetic lethality (SL) has emerged as a novel anticancer strategy that is promising to be highly selective. In the paper “Syn-Lethality: an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies,” X. Li et al. presented Syn-Lethality, the first integrative knowledge base of SL that is dedicated to human cancer. Traditionally, gene sets enrichment analysis of survival related genes is commonly used to reveal the underlying functional mechanisms of complex disease. However, this approach usually produces too many candidate genes and cannot discover detailed signaling transduction cascades, which greatly limits their clinical application such as biomarker development. In the paper “A network biology approach to discover the molecular biomarker associated with hepatocellular carcinoma,” L. Zhuang et al. proposed a network biology approach to discover novel biomarkers from multidimensional omics data. Compared with traditional enrichment analysis, this approach can provide concrete and testable hypothesis on functional mechanism. Furthermore, the identified subnetworks from eighty hepatocellular carcinoma (HCC) expression profiling arrays can potentially be used as suitable targets for therapeutic intervention in HCC. In their paper “Multiple regression analysis of mRNA-miRNA associations in colorectal cancer pathway,” F. Wang et al. adopted a regression model to identify the significantly associated miRNAs targeting a set of candidate genes frequently involved in colorectal cancer (CRC) pathways. Multiple linear regression analysis was used to construct the model and find the significant mRNA-miRNA associations. The results generated from their study would be helpful in the diagnosis and treatment of CRC. In the paper “Network of microRNAs-mRNAs interactions in pancreatic cancer,” E. Naderi et al. constructed the network of miRNA-mRNA interactions for pancreas cancer and illustrated that this network could be used to refine miRNA target predictions for developing new therapeutic approaches. FangXiang Wu Luonan Chen Jianxin Wang Reda Alhajj

CancerNet: a Database for Decoding Multilevel Molecular Interactions Across Diverse Cancer Types

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

CancerPro: Deciphering the Pan-Cancer Prognostic Landscape Through Combinatorial Enrichment Analysis and Knowledge Network Insights

CancerMHL: the database of integrating key DNA methylation, histone modifications and lncRNAs in cancer

Protein-Protein Interaction Reveals Synergistic Discrimination of Cancer Phenotype

CancerProteome: a resource to functionally decipher the proteome landscape in cancer

Integrated Analysis of miRNA and Gene Networks on Cancer Expression Data

MethyCancer: the Database of Human DNA Methylation and Cancer

Transcription factor and microRNA-regulated network motifs for cancer and signal transduction networks

HMNPPID: A Database of Protein-protein Interactions Associated with Human Malignant Neoplasms

Pina 3.0: Mining Cancer Interactome

HCCNet: an integrated network database of hepatocellular carcinoma

A human functional protein interaction network and its application to cancer data analysis

Detecting microbiome species unique or enriched in 20+ cancer types and building cancer microbiome heterogeneity networks

Drug Screening and Biomarker Gene Investigation in Cancer Therapy Through the Human Transcriptional Regulatory Network

TUMIR: an experimentally supported database of microRNA deregulation in various cancers

miRNACancerMAP: an integrative web server inferring miRNA regulation network for cancer

Cancer Network Activity Associated with Therapeutic Response and Synergism.

CancerLinker: Explorations of Cancer Study Network

Establishing Reliable Mirna-Cancer Association Network Based on Text-Mining Method

Biomolecular Networks and Human Diseases